HOOKIPA Pharma Inc (HOOK)
0.9123
-0.01
(-0.70%)
USD |
NASDAQ |
May 03, 16:00
0.9123
0.00 (0.00%)
After-Hours: 20:00
HOOKIPA Pharma Revenue (Quarterly): 7.407M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.407M |
| September 30, 2023 | 6.867M |
| June 30, 2023 | 2.679M |
| March 31, 2023 | 3.176M |
| December 31, 2022 | 7.828M |
| September 30, 2022 | 2.23M |
| June 30, 2022 | 2.746M |
| March 31, 2022 | 1.445M |
| December 31, 2021 | 3.895M |
| September 30, 2021 | 3.874M |
| June 30, 2021 | 5.378M |
| March 31, 2021 | 5.301M |
| Date | Value |
|---|---|
| December 31, 2020 | 5.163M |
| September 30, 2020 | 4.04M |
| June 30, 2020 | 6.685M |
| March 31, 2020 | 3.696M |
| December 31, 2019 | 3.618M |
| September 30, 2019 | 2.038M |
| June 30, 2019 | 4.051M |
| March 31, 2019 | 2.235M |
| December 31, 2018 | 5.08M |
| September 30, 2018 | 1.90M |
| June 30, 2018 | 0.649M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.445M
Minimum
Mar 2022
7.828M
Maximum
Dec 2022
4.322M
Average
3.895M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Gilead Sciences Inc | 6.686B |
| Absci Corp | 0.338M |
| NovaBay Pharmaceuticals Inc | 3.727M |
| Palatin Technologies Inc | 2.034M |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.82M |
| Total Expenses (Quarterly) | 21.83M |
| EPS Diluted (Quarterly) | -0.22 |
| Enterprise Value | -25.07M |
| Profit Margin (Quarterly) | -335.1% |
| Earnings Yield | -96.46% |
| Normalized Earnings Yield | -96.46 |